Crinetics Pharmaceuticals Inc buy JPMorgan Chase & Co.
Start price
20.11.23
/
50%
€27.40
Target price
20.11.24
€32.04
Performance (%)
50.37%
Price
27.06.24
€40.60
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Crinetics Pharmaceuticals Inc has seen massive gains of 50.37%. This prediction currently runs until 20.11.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Crinetics Pharmaceuticals Inc | -1.932% | -1.932% |
iShares Core DAX® | -0.079% | -3.039% |
iShares Nasdaq 100 | 0.247% | 6.421% |
iShares Nikkei 225® | 1.918% | 0.675% |
iShares S&P 500 | 0.146% | 4.708% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $35.00 price target on the stock.
Ratings data for CRNX provided by MarketBeat